Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01305798 · ClinicalTrials.gov registry record · NA
The Effect of Time-Slot Scheduling and Active Choice on Biometric Screening Participation
A NA study, sponsored by National Bureau of Economic Research.
- Completed
- Registry status
- NA
- Development phase
- 11,000
- Enrollment target
NCT01305798: Completed NA study, sponsored by National Bureau of Economic Research.
NCT01305798 is a NA study that has completed, run by National Bureau of Economic Research. The registered enrollment target is 11,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (684% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01305798, a NA study, has completed, sponsored by National Bureau of Economic Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,000 participants
- Enrollment target
Study Summary
The goal of this project is to see if behavioral nudges will increase an individual's likelihood of participating in a biometric screening. The behavioral nudges under consideration are assigning preselected time-slots, encouraging subjects to make an active choice, and sending reminders.
Primary Outcome
We will measure the employee biometric screening completion rates for each arm of the study.
Interventions
- OTHER Scheduling and Active Choice for Biometric Participation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,000 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-08 |
| Phase | NA |
What the finished NCT01305798 record still lists
NCT01305798 is an interventional study that assigns participants to a tested intervention. Its 11,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (684% higher).
The record links to 0 conditions, and to 1 intervention - of which Scheduling and Active Choice for Biometric Participation is the first listed.
NCT01305798 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01305798 about?
NCT01305798 is a clinical study titled "The Effect of Time-Slot Scheduling and Active Choice on Biometric Screening Participation". The goal of this project is to see if behavioral nudges will increase an individual's likelihood of participating in a biometric screening. The behavioral nudges under consideration are assigning preselected time-slots, encouraging subjects to make an active choice, and sending reminders.
What is the current status of trial NCT01305798?
This trial is currently completed. It is a NA study. The enrollment target is 11,000 participants. The study started on 2011-04. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01305798?
The interventions under investigation include: Scheduling and Active Choice for Biometric Participation (OTHER).
Who is sponsoring clinical trial NCT01305798?
This trial is sponsored by National Bureau of Economic Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01305798's enrollment target sits among peer trials
11,000 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- NCT07181109 · 11,000 participants · Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- NCT06736951 · 10,890 participants · NA
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia